fusidic acid has been researched along with iclaprim in 1 studies
| Studies (fusidic acid) | Trials (fusidic acid) | Recent Studies (post-2010) (fusidic acid) | Studies (iclaprim) | Trials (iclaprim) | Recent Studies (post-2010) (iclaprim) |
|---|---|---|---|---|---|
| 1,742 | 117 | 344 | 45 | 7 | 16 |
| Protein | Taxonomy | fusidic acid (IC50) | iclaprim (IC50) |
|---|---|---|---|
| Dihydrofolate reductase | Homo sapiens (human) | 0.486 | |
| Dihydrofolate reductase | Staphylococcus aureus | 0.3076 | |
| Dihydrofolate reductase | Escherichia coli K-12 | 0.4858 | |
| Dihydrofolate reductase | Pneumocystis carinii | 0.9644 | |
| Dihydrofolate reductase | Streptococcus pneumoniae TIGR4 | 0.6055 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hawser, S; Islam, K; Laue, H; Lociuro, S; Seguin, A; Valensise, T | 1 |
1 other study(ies) available for fusidic acid and iclaprim
| Article | Year |
|---|---|
In vitro bactericidal activity of iclaprim in human plasma.
Topics: Anti-Bacterial Agents; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Plasma; Pyrimidines; Staphylococcus aureus | 2009 |